Epidemiological predictions of generalized anxiety disorder, 2032: Focus on the United States, Germany, Spain, Italy, France, United Kingdom and Japan


DUBLIN–(COMMERCIAL WIRE)–The “Generalized Anxiety Disorder – Epidemiological Forecast – 2032” report has been added to ResearchAndMarkets.com offer.

This “Generalized Anxiety Disorder – Epidemiological Forecast to 2032” report provides an in-depth understanding of the disease, historical and predicted epidemiology of Generalized Anxiety Disorder in 7MM, i.e. the United States. States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

Epidemiological perspective of generalized anxiety disorder

The Division of Generalized Anxiety Disorder Epidemiology provides historical and current patient population information and projected trends for each of the seven major countries. The epidemiological data of Generalized Anxiety Disorder are studied through all possible divisions to give a better understanding of the stage of the disease in 7MM.

The Epidemiology of Generalized Anxiety Disorders segment covers epidemiological data in the United States, EU5 countries (Germany, Spain, Italy, France, and United Kingdom) and Japan from 2019 to 2032. It also helps to recognize the causes of current and predicted trends by exploring numerous studies, survey reports and insights from key opinion leaders.

Detailed Segmentation of Generalized Anxiety Disorder Epidemiology

The epidemiology of Generalized Anxiety Disorder covered in the report provides a historical and predicted epidemiological scenario of Generalized Anxiety Disorder in 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France and UK United) and Japan from 2019 to 2032.

The Generalized Anxiety Disorder report also provides the epidemiological trends observed in 7MM over the study period, as well as the assumptions made. The calculated data is presented with relevant tables and graphs to give a clear view of the epidemiology at a glance.

Report scope

  • The Generalized Anxiety Disorder report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment regimens.

  • The Generalized Anxiety Disorder Epidemiology Report and Model provides an overview of global Generalized Anxiety Disorder trends across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK and Japan).

  • The report provides information on the historical and forecast population of patients with generalized anxiety disorder in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, United Kingdom) and Japan.

  • The report helps to recognize 7MM growth opportunities for the patient population

  • Report assesses risk and disease burden and highlights unmet needs in generalized anxiety disorder

  • The report provides a segmentation of the epidemiology of generalized anxiety disorder

Report Highlights

  • 11-year prognosis of the epidemiology of Generalized Anxiety Disorder

  • 7MM cover

  • Prevalent and diagnosed cases of generalized anxiety disorder

  • Generalized Anxiety Disorder Cases by Mutation Types

  • Case of generalized anxiety disorder associated with clinical manifestations

KOL Views

The editor polls the opinion of KOL and SME through primary research to fill data gaps and validate our secondary research. The opinion helps to understand the total patient population and the current treatment regimen. This will help clients in possible new upcoming treatment by identifying the general scenario of indications.

Answers to key questions

  • What will be the growth opportunities in 7MM for the Generalized Anxiety Disorder patient population?

  • What are the key findings related to the epidemiology of generalized anxiety disorder in 7MM and which country will have the most patients during the forecast period (2019-2032)?

  • What would be the total number of patients with generalized anxiety disorder in 7MM during the forecast period (2019-2032)?

  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?

  • At what CAGR is the patient population expected to grow by 7 million over the forecast period (2019-2032)?

  • What are the disease risk, burden and unmet needs of generalized anxiety disorder?

  • What treatments are currently available for generalized anxiety disorder?

Main topics covered:

1. Key information

2. Executive Summary of Generalized Anxiety Disorder

3. Generalized anxiety disorder: background and general description of the illness

3.1. Introduction

3.2. Sign and symptoms

3.3. pathophysiology

3.4. Risk factors

3.5. Diagnostic

4. Patient journey

5. Epidemiology and patient population

5.1. Main lessons from epidemiology

5.2. Assumptions and justification: 7MM

5.3. Epidemiological scenario: 7MM

5.3.1. Epidemiological scenario of generalized anxiety disorder in 7MM (2019-2032)

5.4. united states epidemiology

5.5. Epidemiology by EU-5 country

5.5.1. Germany Epidemiology

5.5.2. France Epidemiology

5.5.3. Italy Epidemiology

5.5.4. Spain Epidemiology

5.5.5. British epidemiology

5.6. Japan Epidemiology

6. Treatment Algorithm, Current Treatment and Medical Practices

6.1. Treatment and management of generalized anxiety disorder

6.2. Generalized anxiety disorder treatment algorithm

7. KOL Views

8. Unmet Needs

9. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/vay2dk

Laisser un commentaire